Adaptive designs for binary treatment responses in phase III clinical trials: controversies and progress
From MaRDI portal
Publication:5424121
DOI10.1177/096228020101000504zbMath1121.62577OpenAlexW2077010955MaRDI QIDQ5424121
Publication date: 2 November 2007
Published in: Statistical Methods in Medical Research (Search for Journal in Brave)
Full work available at URL: https://doi.org/10.1177/096228020101000504
Related Items (2)
Ethics, data-dependent designs, and the strategy of clinical trials: time to start learning-as-we-go? ⋮ An adaptive allocation design for circular treatment outcome
Cites Work
- Continual Reassessment Method: A Practical Design for Phase 1 Clinical Trials in Cancer
- The generalized Polya's urn design for sequential medical trials
- Asymptotic inference with response-adaptive treatment allocation designs
- Estimation for an adaptive allocation design
- Variance in randomized play-the-winner clinical trials
- Investigating therapies of potentially great benefit: ECMO. With comments and a rejoinder by the author
- Ethics and statistics in randomized clinical trials. With comments and a rejoinder by the author
- On inferences from Wei's biased coin design for clinical trials
- Randomized play the winner clinical trials
- Exact two-sample permutation tests based on the randomized play-the-winner rule
- A Treatment Allocation Procedure for Sequential Clinical Trials
- Optimum biased coin designs for sequential clinical trials with prognostic factors
- A sequential design for maximizing the probability of a favourable response
- Sequential comparison of two treatments in clinical trials:a decision theoretic approach based on randomized play-the-winner rule
- Delayed response in randomized play-the-winner rule revisited
- A class of adaptive designs
- The Comparison of Designs for Sequential Clinical Trials with Covariate Information
- A randomized play-the-winner design for multi-arm clinical trials
- Forcing a sequential experiment to be balanced
- Some aspects of the sequential design of experiments
This page was built for publication: Adaptive designs for binary treatment responses in phase III clinical trials: controversies and progress
